Omeros (NASDAQ:OMER)

CAPS Rating: 2 out of 5

OMER News and Commentary

  • Oh, Omeros.September 16, 2013 Blog at The Motley Fool

Caps

How do you think OMER will perform against the market?

Add Stock to CAPS Watchlist

All Players

74 Outperform
28 Underperform
 

All-Star Players

12 Outperform
11 Underperform
 

Wall Street

5 Outperform
0 Underperform
 

Top OMER Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

zzlangerhans (99.83)
Submitted April 08, 2014

Perhaps the secret PDUFA date for Omidria is keeping Omeros off run-up traders' catalyst calendars. The stock has been decidedly weak ahead of the FDA approval decision, which I project will occur in early June. Meanwhile, Omeros is attempting to… More

zzlangerhans (99.83)
Submitted December 30, 2011

2011 wasn't a very good year for the "repurposers", pharmas that utilize the strategy of suddenly discovering fascinating new powers of cheap off-patent ancient drugs. Among the roadkill are Zalicus, Rexahn, and Ampio. Omeros already suffered one… More

OMER VS S&P 500 (SPY)

OMER Summary

Recent Community Commentary

Read the most recent pitches from players about OMER.

Recs

0
Member Avatar TMFang4apples (55.90) Submitted: 9/26/2017 9:35:20 AM : Outperform Start Price: $10.80 OMER Score: +66.99

Omeros' lead candidate has a huge potential to treat rare autoimmune disorders, and Omidria sales are growing by leaps and bounds.

Recs

0
Member Avatar TMFTypeoh (85.44) Submitted: 3/19/2017 11:24:54 AM : Outperform Start Price: $10.80 OMER Score: +66.99

OMS721 could be a winner.

Recs

0
Member Avatar adamicius (< 20) Submitted: 2/27/2017 3:11:19 PM : Outperform Start Price: $12.14 OMER Score: +47.72

Early stage biotech (only one commercialised drug, others in pipeline), so lots of risk involved. In a word: potential.

Leaderboard

Find the members with the highest scoring picks in OMER.

Score Leader

vin100r

vin100r (< 20) Score: +372.79

The Score Leader is the player with the highest score across all their picks in OMER.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
vin100r < 20 8/15/2011 Outperform 3W $3.22 +488.51% +115.71% +372.79 0 Comment
KidJones 30.32 4/18/2013 Outperform 5Y $3.86 +390.93% +66.38% +324.55 0 Comment
jack0071 72.16 5/15/2013 Outperform 5Y $4.86 +289.92% +55.09% +234.83 0 Comment
B4ngZ00m < 20 3/4/2013 Outperform 5Y $5.35 +254.21% +69.42% +184.79 0 Comment
Biotechbillions < 20 7/16/2013 Outperform 5Y $5.77 +228.42% +52.81% +175.62 0 Comment
stover87 < 20 2/4/2013 Outperform 1Y $5.61 +237.79% +71.12% +166.67 1 Comment
stainsolution < 20 2/12/2013 Outperform 5Y $5.73 +230.72% +69.40% +161.32 0 Comment
TRSHLog 78.75 1/18/2013 Outperform 3M $5.68 +233.63% +74.09% +159.54 0 Comment
jacbthom 72.27 9/16/2013 Outperform 5Y $6.35 +198.43% +50.63% +147.80 0 Comment
pcguy < 20 11/25/2013 Outperform 5Y $7.20 +163.19% +41.95% +121.25 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJimCramer 84.96 7/25/2014 Outperform 3W $13.98 +35.55% +30.04% +5.51 0 Comment
TrackRodmanRen < 20 12/6/2011 Outperform NS $4.01 +372.57% +103.72% +268.85 0 Comment
TrackRodmanRen < 20 9/10/2010 Outperform NS $6.35 -18.58% +20.18% -38.76 4/1/2011 @ $5.17 0 Comment
TrackNeedham 91.52 12/2/2009 Outperform NS $7.02 +10.81% +19.79% -8.98 3/31/2011 @ $7.78 0 Comment
TrackWedbush 84.84 11/20/2009 Outperform NS $7.55 +150.99% +135.04% +15.95 0 Comment
TrackCanaccord 45.61 11/18/2009 Outperform NS $6.98 +171.49% +131.80% +39.69 0 Comment
TrackDeutscheSec 90.19 11/18/2009 Outperform NS $6.98 -24.93% +20.34% -45.27 4/1/2011 @ $5.24 0 Comment
trackwbbsecuriti < 20 10/26/2009 Outperform NS $6.64 +185.39% +135.73% +49.66 0 Comment

Featured Broker Partners